4.7 Article

Mammographic Density Reduction Is a Prognostic Marker of Response to Adjuvant Tamoxifen Therapy in Postmenopausal Patients With Breast Cancer

Related references

Note: Only part of the references are listed.
Article Statistics & Probability

TheRcmdrPlugin.survivalPackage: Extending theRCommander Interface to Survival Analysis

John Fox et al.

Journal of Statistical Software (2015)

Article Public, Environmental & Occupational Health

The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research

Jonas F. Ludvigsson et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2009)

Article Medicine, General & Internal

Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen

Werner Schroth et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

Article Oncology

Risk factors for hormone receptor-defined breast cancer in postmenopausal women

Lena U. Rosenberg et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)

Article Oncology

Measurements of breast density: No ratio for a ratio

G Haars et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)

Article Oncology

Tamoxifen and breast density in women at increased risk of breast cancer

J Cuzick et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)

Article Oncology

Postmenopausal hormone therapy and change in mammographic density

GA Greendale et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)

Article Oncology

Comparison of mammographic densities and their determinants in women from Japan and Hawaii

G Maskarinec et al.

INTERNATIONAL JOURNAL OF CANCER (2002)

Article Radiology, Nuclear Medicine & Medical Imaging

Can tamoxifen cause a significant mammographic density change in breast parenchyma?

O Konez et al.

CLINICAL IMAGING (2001)